Overexpression of the prolyl isomerase PIN1 promotes cell growth in osteosarcoma cells

Zhou,Lu; Park,Byung-Hyun; Park,Jong  Hyuk; Jang,Kyu  Yun; Park,Ho  Sung; Wagle,Sajeev; Lee,Kwang-Bok; Kim,Jung  Ryul

doi:10.3892/or.2012.2112

Overexpression of the prolyl isomerase PIN1 promotes cell growth in osteosarcoma cells

Authors:
- Lu Zhou
- Byung-Hyun Park
- Jong Hyuk Park
- Kyu Yun Jang
- Ho Sung Park
- Sajeev Wagle
- Kwang-Bok Lee
- Jung Ryul Kim
View Affiliations

Affiliations: Department of Orthopaedic Surgery, Chonbuk National University Medical School, Jeonju, Jeonbuk 561-756, Republic of Korea, Department of Biochemistry, Chonbuk National University Medical School, Jeonju, Jeonbuk 561-756, Republic of Korea, Department of Pathology, Chonbuk National University Medical School, Jeonju, Jeonbuk 561-756, Republic of Korea
Published online on: October 30, 2012 https://doi.org/10.3892/or.2012.2112
Pages: 193-198

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

PIN1 was recently identified as a peptidyl-prolyl cis-trans isomerase (PPIase). It binds to and isomerizes specific pSer/Thr-Pro motifs and catalytically induces conformational changes after phosphorylation. PIN1 plays an important role in several cellular events, such as cell cycle progression, transcriptional regulation, RNA processing, cell proliferation and differentiation. The relationship between PIN1 and osteosarcoma has not been previously studied. In the present study, we investigated the expression pattern of PIN1 in human osteosarcoma tissues and the role of PIN1 in osteosarcoma generation and development. The expression levels of PIN1 were detected by immunohistochemistry and western blotting. Results demonstrated that the expression of PIN1, cyclin D1 and β-catenin were significantly higher in human osteosarcoma tissues compared to normal tissues. The in vitro effects of PIN1 overexpression were studied in human osteosarcoma cell lines. Adenovirus-mediated PIN1 overexpression significantly stimulated the proliferation of MG-63 and U2-OS osteosarcoma cells by 148±10.5 and 187±21.5%, respectively. In FACS analysis, U2-OS cells displayed significant levels of arrest in cell cycle progression at the G0/G1 phase. Consistent with increased cell growth, levels of cyclin D1 and cyclin E and their associated cyclin-dependent kinases, CDK4 and CDK6, were enhanced in PIN1-overexpressed cells compared with the control virus-transfected cells. When the PIN1 inhibitor juglone was added to the cells, the proliferative effects of PIN1 were abolished. These results suggest that PIN1 may play an important role in tumorigenesis and tumor progression of osteosarcoma and therefore, provide a new target for gene therapy.

View Figures

View References

1	Galat A: Peptidylprolyl cis/trans isomerases (immunophilins): biological diversity - targets - functions. Curr Top Med Chem. 3:1315–1347. 2003. View Article : Google Scholar : PubMed/NCBI
2	Lu KP, Suizu F, Zhou XZ, Finn G, Lam P and Wulf G: Targeting carcinogenesis: a role for the prolyl isomerase Pin1? Mol Carcinog. 45:397–402. 2006. View Article : Google Scholar : PubMed/NCBI
3	Lu KP, Hanes SD and Hunter T: A human peptidyl-prolyl isomerase essential for regulation of mitosis. Nature. 380:544–547. 1996. View Article : Google Scholar : PubMed/NCBI
4	Blume-Jensen P and Hunter T: Oncogenic kinase signalling. Nature. 411:355–365. 2001. View Article : Google Scholar : PubMed/NCBI
5	Hunter T: Prolyl isomerases and nuclear function. Cell. 92:141–143. 1998. View Article : Google Scholar : PubMed/NCBI
6	Berger M, Stahl N, Del Sal G and Haupt Y: Mutations in proline 82 of p53 impair its activation by Pin1 and Chk2 in response to DNA damage. Mol Cell Biol. 25:5380–5388. 2005. View Article : Google Scholar : PubMed/NCBI
7	Albert A, Lavoie S and Vincent M: A hyperphosphorylated form of RNA polymerase II is the major interphase antigen of the phosphoprotein antibody MPM-2 and interacts with the peptidyl-prolyl isomerase Pin1. J Cell Sci. 112:2493–2500. 1999.PubMed/NCBI
8	Liou YC, Ryo A, Huang HK, et al: Loss of Pin1 function in the mouse causes phenotypes resembling cyclin D1-null phenotypes. Proc Natl Acad Sci USA. 99:1335–1340. 2002. View Article : Google Scholar : PubMed/NCBI
9	Ryo A, Nakamura M, Wulf G, Liou YC and Lu KP: Pin1 regulates turnover and subcellular localization of beta-catenin by inhibiting its interaction with APC. Nat Cell Biol. 3:793–801. 2001. View Article : Google Scholar : PubMed/NCBI
10	Yaffe MB, Schutkowski M, Shen M, et al: Sequence-specific and phosphorylation-dependent proline isomerization: a potential mitotic regulatory mechanism. Science. 278:1957–1960. 1997. View Article : Google Scholar
11	Zhou XZ, Kops O, Werner A, et al: Pin1-dependent prolyl isomerization regulates dephosphorylation of Cdc25C and tau proteins. Mol Cell. 6:873–883. 2000. View Article : Google Scholar : PubMed/NCBI
12	Fujimori F, Takahashi K, Uchida C and Uchida T: Mice lacking Pin1 develop normally, but are defective in entering cell cycle from G(0) arrest. Biochem Biophys Res Commun. 265:658–663. 1999. View Article : Google Scholar : PubMed/NCBI
13	Maleszka R, Hanes SD, Hackett RL, de Couet HG and Miklos GL: The Drosophila melanogaster dodo (dod) gene, conserved in humans, is functionally interchangeable with the ESS1 cell division gene of Saccharomyces cerevisiae. Proc Natl Acad Sci USA. 93:447–451. 1996.
14	Hsu T, McRackan D, Vincent TS and Gert de Couet H: Drosophila Pin1 prolyl isomerase Dodo is a MAP kinase signal responder during oogenesis. Nat Cell Biol. 3:538–543. 2001. View Article : Google Scholar
15	Wulf GM, Ryo A, Wulf GG, et al: Pin1 is overexpressed in breast cancer and cooperates with Ras signaling in increasing the transcriptional activity of c-Jun towards cyclin D1. EMBO J. 20:3459–3472. 2001. View Article : Google Scholar : PubMed/NCBI
16	Miyashita H, Uchida T, Mori S, Echigo S and Motegi K: Expression status of Pin1 and cyclins in oral squamous cell carcinoma: Pin1 correlates with cyclin D1 mRNA expression and clinical significance of cyclins. Oncol Rep. 10:1045–1048. 2003.PubMed/NCBI
17	Lee JH, Song MY, Song EK, et al: Overexpression of SIRT1 protects pancreatic beta-cells against cytokine toxicity by suppressing the nuclear factor-kappaB signaling pathway. Diabetes. 58:344–351. 2009. View Article : Google Scholar : PubMed/NCBI
18	Ayala G, Wang D, Wulf G, et al: The prolyl isomerase Pin1 is a novel prognostic marker in human prostate cancer. Cancer Res. 63:6244–6251. 2003.PubMed/NCBI
19	Bao L, Kimzey A, Sauter G, Sowadski JM, Lu KP and Wang DG: Prevalent overexpression of prolyl isomerase Pin1 in human cancers. Am J Pathol. 164:1727–1737. 2004. View Article : Google Scholar : PubMed/NCBI
20	Chen SY, Wulf G, Zhou XZ, Rubin MA, Lu KP and Balk SP: Activation of beta-catenin signaling in prostate cancer by peptidyl-prolyl isomerase Pin1-mediated abrogation of the androgen receptor-beta-catenin interaction. Mol Cell Biol. 26:929–939. 2006. View Article : Google Scholar : PubMed/NCBI
21	Fukuchi M, Fukai Y, Kimura H, et al: Prolyl isomerase Pin1 expression predicts prognosis in patients with esophageal squamous cell carcinoma and correlates with cyclin D1 expression. Int J Oncol. 29:329–334. 2006.PubMed/NCBI
22	Kim CJ, Cho YG, Park YG, et al: Pin1 overexpression in colorectal cancer and its correlation with aberrant beta-catenin expression. World J Gastroenterol. 11:5006–5009. 2005.PubMed/NCBI
23	Kokkinakis DM, Liu X and Neuner RD: Modulation of cell cycle and gene expression in pancreatic tumor cell lines by methionine deprivation (methionine stress): implications to the therapy of pancreatic adenocarcinoma. Mol Cancer Ther. 4:1338–1348. 2005. View Article : Google Scholar
24	Kuramochi J, Arai T, Ikeda S, Kumagai J, Uetake H and Sugihara K: High Pin1 expression is associated with tumor progression in colorectal cancer. J Surg Oncol. 94:155–160. 2006. View Article : Google Scholar : PubMed/NCBI
25	He J, Zhou F, Shao K, et al: Overexpression of Pin1 in non-small cell lung cancer (NSCLC) and its correlation with lymph node metastases. Lung Cancer. 56:51–58. 2007. View Article : Google Scholar : PubMed/NCBI
26	Clurman BE and Roberts JM: Cell cycle and cancer. J Natl Cancer Inst. 87:1499–1501. 1995. View Article : Google Scholar : PubMed/NCBI
27	Sherr CJ: Cancer cell cycles. Science. 274:1672–1677. 1996. View Article : Google Scholar : PubMed/NCBI
28	Jacks T and Weinberg RA: Cell-cycle control and its watchman. Nature. 381:643–644. 1996. View Article : Google Scholar : PubMed/NCBI
29	Pestell RG, Albanese C, Reutens AT, Segall JE, Lee RJ and Arnold A: The cyclins and cyclin-dependent kinase inhibitors in hormonal regulation of proliferation and differentiation. Endocr Rev. 20:501–534. 1999.PubMed/NCBI
30	Yeh ES, Lew BO and Means AR: The loss of PIN1 deregulates cyclin E and sensitizes mouse embryo fibroblasts to genomic instability. J Biol Chem. 281:241–251. 2006. View Article : Google Scholar : PubMed/NCBI
31	Yeh E, Cunningham M, Arnold H, et al: A signalling pathway controlling c-Myc degradation that impacts oncogenic transformation of human cells. Nat Cell Biol. 6:308–318. 2004. View Article : Google Scholar : PubMed/NCBI
32	Xiong Y, Hannon GJ, Zhang H, Casso D, Kobayashi R and Beach D: p21 is a universal inhibitor of cyclin kinases. Nature. 366:701–704. 1993. View Article : Google Scholar : PubMed/NCBI
33	Kim MR, Choi HK, Cho KB, Kim HS and Kang KW: Involvement of Pin1 induction in epithelial-mesenchymal transition of tamoxifen-resistant breast cancer cells. Cancer Sci. 100:1834–1841. 2009. View Article : Google Scholar : PubMed/NCBI